Lisa Wilson | IR |
Brian Markison | CEO |
Mike DePetris | Interim CFO |
JD Schaub | COO |
Louise Chen | Cantor |
Douglas Tsao | H.C Wainwright |
Michaela Diverio | Barclays |
Good day and thank you for standing by. Welcome to the RVL Pharmaceuticals Second Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator instructions] Please be advised that today's conference is being recorded.